Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2003
03/20/2003US20030055093 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
03/20/2003US20030055084 Pharmaceutical compounds and methods of use thereof
03/20/2003US20030055080 Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
03/20/2003US20030055077 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
03/20/2003US20030055068 Pyrazole compounds useful as protein kinase inhibitors
03/20/2003US20030055054 CXCR3 antagonists
03/20/2003US20030055044 Administering pyrazole derivative for inhibiting GSK-3 or Aurora activity in a patient
03/20/2003US20030055035 Useful in hyperpolarizing cell membranes, opening potassium channels, relaxing smooth muscle cells, and inhibiting bladder contractions
03/20/2003US20030055034 Preparing a concentrated inhalable aztreonam formulation comprising aztreonam dissolved in an aerosolable solution; delivering aztreonam dry powder or the aerosolable solution to the lung endobronchial space of airways of a patient
03/20/2003US20030055030 Administering 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride for therapy of inflammatory disease or inflammation-associated disorder
03/20/2003US20030055026 Formoterol/steroid bronchodilating compositions and methods of use thereof
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054974 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/20/2003US20030054532 Reduction in aggregation of enzymes in liquid solutions; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in aggregation activity
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054037 Pharmaceutical compositions of adsorbates of amorphous drug
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053958 For treating pulmonary hypertension; sustained release; has no effect on heart rate
03/20/2003US20030053957 Degradation-resistant glucocorticosteroid formulations
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459882A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
03/20/2003CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003CA2459533A1 Methods of treating pulmonary disease
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459364A1 Ccr-3 receptor antagonists v
03/20/2003CA2458029A1 Methods of treating cytokine mediated diseases
03/20/2003CA2457717A1 Use of compounds in a dry powder inhaler
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293131A1 Throat care agents
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292590A1 Admantane derivatives
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292563A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
03/19/2003EP1292363A2 Carboxyalkylether-acat inhibitor combinations
03/19/2003EP1292347A1 Drug delivery apparatus
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
03/19/2003EP1292286A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist
03/19/2003EP1292281A1 Novel tiotropium-containing inhalation powder
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1080069B1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP1014812B1 Smoking products containing antioxidants
03/19/2003EP1011686A4 Modulation of human mast cell activation
03/19/2003EP0944636B1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404474A Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404396A Polypeptoid pulmonary surfactants
03/19/2003CN1404391A Treating allergic and inflammatory conditions
03/19/2003CN1404388A Multi-step drug dosage forms
03/19/2003CN1403130A Cough-relieving bagged tea and its prepn
03/19/2003CN1403076A Multi-particle improved release composition
03/19/2003CN1103229C Electuary for treating allergic respiratory system diseases
03/19/2003CN1103224C Chinese patent medicine for treating cold cough and its preparing process
03/18/2003US6534534 Administering indazole-3-methyleneoxyalkanoic acid derivative to treat atherosclerosis
03/18/2003US6534519 Phenanthridine-N-oxides with PDE-IV inhibiting activity
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534510 Anticoagulants
03/18/2003US6534486 With broad anti-inflammatory properties which inhibit leukocyte recruitment and activation and which are agonists of the adenosine 2a receptor are described.
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6532955 Metered dose inhaler for albuterol
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020700A2 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
03/13/2003WO2003020325A2 Methods for sterilizing preparations containing albumin
03/13/2003WO2003020324A2 Methods for sterilizing preparations of digestive enzymes
03/13/2003WO2003020313A1 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
03/13/2003WO2003020304A2 Inflammation modulatory compound comprising an endomorphin
03/13/2003WO2003020290A1 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020275A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
1 ... 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 ... 878